Catherine Stehman-Breen

Catherine Stehman-Breen

Chief Tech/Sci/R&D Officer at DYNE THERAPEUTICS, INC.

Net worth: 3 M $ as of 2024-02-28

61 year
Health Technology
Consumer Services
Finance

Profile

Presently, Catherine Stehman-Breen holds the position of Chief Executive Officer & Director at Chroma Medicine, Inc., Director & Chief Medical Officer at Dyne Therapeutics, Inc. and Advisor at Atlas Venture Advisors, Inc., Advisor at Atlas Venture Life Science Advisors LLC (a subsidiary of Atlas Venture Advisors, Inc.).
She is also on the board of Generation Bio Co. and Tenaya Therapeutics, Inc. and Associate Professor at UW School of Public Health.
In her past career Dr. Stehman-Breen was Chief Medical Officer at Sarepta Therapeutics, Inc., Vice President-Global Development at Amgen, Inc., Chief Research & Development Officer at Obsidian Therapeutics, Inc., VP-Clinical Development & Regulatory Affairs at Regeneron Pharmaceuticals, Inc., Chairman-United States Renal Data System at National Institute of Diabetes & Digestive & Kidney Diseases and Chief Medical Officer at Disarm Therapeutics, Inc. Catherine Stehman-Breen received a doctorate from The University of Chicago, a graduate degree from the University of Washington and an undergraduate degree from Colby College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-23 115,713 ( 0.14% ) 3 M $ 2024-02-28
2023-06-07 47,523 ( 0.07% ) 119 283 $ 2024-02-28
2023-06-08 8,125 ( 0.01% ) 48 344 $ 2024-02-28

Catherine Stehman-Breen active positions

CompaniesPositionStart
GENERATION BIO CO. Director/Board Member 2017-11-30
DYNE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2019-06-27
TENAYA THERAPEUTICS, INC. Director/Board Member 2020-05-31
Chief Executive Officer 2020-11-30
UW School of Public Health Corporate Officer/Principal -
Consultant / Advisor 2018-02-28
Consultant / Advisor 2018-02-28
All active positions of Catherine Stehman-Breen

Former positions of Catherine Stehman-Breen

CompaniesPositionEnd
Corporate Officer/Principal 2020-11-30
Corporate Officer/Principal 2019-06-30
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Catherine Stehman-Breen's experience

Training of Catherine Stehman-Breen

University of Washington Graduate Degree
Colby College Undergraduate Degree
The University of Chicago Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Catherine Stehman-Breen's experience

Connections

99

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
AMGEN INC.

Health Technology

REGENERON PHARMACEUTICALS, INC.

Health Technology

SAREPTA THERAPEUTICS, INC.

Health Technology

GENERATION BIO CO.

Health Technology

TENAYA THERAPEUTICS, INC.

Health Technology

DYNE THERAPEUTICS, INC.

Health Technology

Private companies6

Finance

National Institute of Diabetes & Digestive & Kidney Diseases

Government

Finance

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Catherine Stehman-Breen